Bausch Health Companies (BHC) Tax Rate (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Tax Rate came in at 25.29% in Q2 2026, up 1672.0% year-over-year from 1.43% in Q2 2025, and up 544.66% quarter-over-quarter from 5.69% in Q1 2026.
Analysis
Bausch Health Companies (BHC) Tax Rate (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Tax Rate across 18 years of filings, most recently posting 25.29% for Q2 2026.
- In Q2 2026, Tax Rate rose 1672.0% year-over-year to 25.29%; the TTM figure through Jun 2026 stood at 49.32% (down 13224.0% YoY), while the FY2025 annual figure was 67.3%, down 7581.0% from the prior year.
- Tax Rate came in at 25.29% for Q2 2026 at Bausch Health Companies, up from 5.69% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 283.93% in Q4 2025 to a low of 571.43% in Q4 2023.
- Average Tax Rate over 5 years is 28.87%, with a median of 1.26% recorded in 2022.
- Year-over-year, Tax Rate sank 55658 bps in 2023 and soared 62454 bps in 2024.
- Over 5 years, Tax Rate stood at 14.85% in 2022, then tumbled by 3749 bps to 571.43% in 2023, then jumped by 109 bps to 53.11% in 2024, then jumped by 435 bps to 283.93% in 2025, then tumbled by 91 bps to 25.29% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 25.29% in Q2 2026, 5.69% in Q1 2026, and 283.93% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -26.59% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -85.63% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 21.32% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.94% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 25.29% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.09% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 33.43% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 21.26% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 2.08% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.29% |
| Mar 31, 2026 | -5.69% |
| Dec 31, 2025 | 283.93% |
| Sep 30, 2025 | 16.97% |
| Jun 30, 2025 | 8.57% |
| Mar 31, 2025 | -82.98% |
| Dec 31, 2024 | 53.11% |
| Sep 30, 2024 | -338.10% |
| Jun 30, 2024 | 102.08% |
| Mar 31, 2024 | -11.59% |
| Dec 31, 2023 | -571.43% |
| Sep 30, 2023 | -17.18% |
| Jun 30, 2023 | 65.82% |
| Mar 31, 2023 | -53.68% |
| Dec 31, 2022 | -14.85% |
| Sep 30, 2022 | 8.20% |
| Jun 30, 2022 | -7.75% |
| Mar 31, 2022 | 19.51% |
| Dec 31, 2021 | -242.86% |
| Sep 30, 2021 | 11.57% |